Strange Behavior at the F.D.A.

Published: November 15, 2005

Congressional investigators have documented some highly suspect maneuvering behind the Food and Drug Administration's decision last year to reject over-the-counter sales of the controversial morning-after contraceptive known as Plan B. The investigation, by the Government Accountability Office, stopped short of asserting that political considerations had led agency officials to overrule their own experts and outside advisers. But the most plausible inference one can draw is that politics or ideology was allowed to trump science as higher-ups at the agency searched for rationales to keep access to the contraceptive restricted.